Remove companies american-civil-liberties-union
article thumbnail

Congress Considers Kids Online Safety Act Amid Concerns from Activists        

LexBlog IP

According to bill sponsors Senator Richard Blumenthal (D-CT) and Marsha Blackburn (R-TN), KOSA would require social media companies to develop enhanced parental controls for online platforms. The Kids Online Safety Act (KOSA) of 2023 is circulating Congress with bipartisan support.

article thumbnail

Fish & Richardson Attorneys Megan Chacon and Crystal Culhane Named 2021 Women of Influence in Law by the San Diego Business Journal

Fish & Richardson Trademark & Copyright Thoughts

She currently represents Gilead Sciences, one of the largest and most well-known biotechnology companies in the world, in multiple patent litigation matters. Beyond her litigation practice, Chacon serves as pro bono counsel to various organizations, including the American Civil Liberties Union San Diego.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Biden administration releases wide-ranging executive order on AI

LexBlog IP

The European Union and China have already started to regulate AI. Support American workers through education, job training and labor impact understanding. Advance equity and civil rights. Protect the interests of Americans using AI products in their daily lives.

article thumbnail

Guest Post: Assessing Responses to the PTO’s 2021 Patent Eligibility Study

Patently-O

Companies and trade associations were broadly classified as “High Tech” (18%) or “Life Sciences” (14%). Notable commenters in this camp include the American Civil Liberties Union (ACLU), Google, and the Association of American Medical Colleges (AAMC). .

Patent 120
article thumbnail

United States Bill S. 4734: Should Diagnostic Tests be Eligible for Patent Protection

IPilogue

There is currently a congressional push to let drug companies patent diagnostic tests in the United States. Thus, there may be a better way to both reward biotech companies for their creation of diagnostic methods and prevent harmful monopolies over essential lifesaving inventions. This push comes from Senator Thom Tills.

Patent 105